Industry Insights

  1. Why Passing Audits No Longer Predicts Scale 10/8/2026

    Clean audit results confirm past compliance but say little about future performance. As products, markets, and regulations multiply, readiness depends on whether evidence stays connected.

  2. Why Audit Success No Longer Predicts Clinical-Stage Performance 10/8/2026

    Passing inspections no longer signals that a growth-stage biotech can sustain clinical-stage complexity. The gap between audit readiness and operational readiness opens quietly.

  3. 5 Hidden Risks In Manual Life Science GRC Systems 10/8/2026

    Spreadsheets and siloed quality systems conceal five compounding exposures, from single-person knowledge dependencies to scalability limits, that tend to surface only when an inspector finds them.

  4. Navigating Recent Changes To USP <788> 9/29/2026

    A recent USP <788> revision introduces meaningful changes to particulate matter testing methods, with implications for laboratories working with small-volume injectable products.

  5. A Risk-Based Approach To EO Residual Limits 9/29/2026

    ISO 10993-7:2026 replaces table-based EO residual limits with a risk-based framework that requires manufacturers to justify limits based on device-specific and patient-specific factors.

  6. Why Micro Manufacturing Needs "Architecture" Not Just Production 9/28/2026

    Discover why micro molding requires a complete manufacturing architecture integrating design, tooling, automation, metrology, production, and packaging to achieve predictable, repeatable results at scale.

  7. The People Who Turn An Idea Into A Deliverable Product 9/15/2026

    Drug developers and device engineers share more common ground than their distinct disciplines suggest, facing parallel pressures around design, safety, regulatory approval, and scalable performance.

  8. 8 Regulations Every Biotech & Pharma Quality Leader Must Know 9/14/2026

    Navigate essential biotech and pharma regulations safely. Learn how unifying global standards streamlines audits and accelerates development schedules.

  9. The Life Sciences Guide To AI In Quality & Compliance 9/14/2026

    Implement AI in quality workflows without regulatory risk. Learn how strong governance and clear validation keep you audit-ready for compliance.

  10. Advancing Biopsy Device Performance Through Precision Overmolding And Assembly 9/2/2026

    Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.